INS and metabolic disease: In contrast, the TyG-BMI, with its multiple advantages of low cost, easy accessibility, independence from insulin therapy, and more comprehensive assessment of metabolic health, not only correlates strongly with HOMA-IR, but also better predicts metabolic diseases such as diabetes and cardiovascular disease (27, 30, 31).